Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Data Science with Semantic Technologies: Deployment and Exploration ; : 103-114, 2023.
Article in English | Scopus | ID: covidwho-20237607

ABSTRACT

For past few years the entire world has been facing an unprecedented situation with the coronavirus outbreak. Covid-19 has a tremendous effect on economic, social, societal, and health systems which has made humans experience the unexpected. As of late October, 2020, it had infected more than 40 million people worldwide. The pandemic has impacted health systems and medical resource availability in several nations throughout the world, leading to the high mortality rate. By using the technology like data science, one can monitor individuals on regular basis who are suspected to be infected with Covid-19. Managing an epidemic involves a comprehensive understanding of the disease's characteristics and behaviour, which may be uncovered by collecting and analysing relevant data. There are several useful things that can help enhance healthcare facilities. As a result, the data science community is working to understand an artificial intelligence (AI)-guided solution. Big data analytics tools are essential for getting the skills required to make choices and take necessary precautions. In order to stop the spread of Covid-19, the effectiveness of data analysis must be evaluated. The main issues and future directions of Covid-19 data analysis are discussed. In this chapter, we review the role that data science is playing in this pandemic. © 2023 selection and editorial matter, Archana Patel, Narayan C. Debnath;individual chapters, the contributors.

3.
Indian Journal of Urology ; 39(5 Supplement 1):S73, 2023.
Article in English | EMBASE | ID: covidwho-2259990

ABSTRACT

Introduction and Objectives: In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause of a cluster of pneumonia cases in China, and the corresponding disease was designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world resulting in a pandemic. COVID-19 is associated with a set of coagulation abnormalities that increase the risk of thromboembolic events. Material(s) and Method(s): We report series of five cases of acute pulmonary thromboembolism following endourological procedures, treated in our tertiary care center, which after an apparent clinical improvement, developed acute pulmonary thrombo-embolism between second and third post-op day. Results and Observations: Among five cases, three were post PCNL and two post URSL. All Patients presented with dyspnoea, tachycardia, desaturation and hypotension. Further investigated with E.C.G, D-dimer, 2D-echo and CT-pulmonary angiogram, all suggestive of PTE. Hence patients were managed sucessfully in CCU with cardiologist advice and timely intrevention. Among five, three were managed with IV thrombolytic and anticoagulant therapy and two managed with IV anticoagulation alone , dose monitored with periodic coagulation profile. All patients discharged with oral newer anticoagulants and periodic follow up for 6 months. All patients on follow up and doing well. Conclusion(s): Thromboembolic events are potential complication of COVID-19 and can manifest later. Although very rare after endourological procedures, it requires high index of suspicion so as not to be missed as diagnosis, especially in hemodynamically unstable patients with respiratory distress. Early diagnosis and proper therapeutic actions is crucial for patients.

4.
Acta Crystallographica a-Foundation and Advances ; 78:A194-A194, 2022.
Article in English | Web of Science | ID: covidwho-2222985
5.
Journal of Phytology ; 13:192-202, 2021.
Article in English | Scopus | ID: covidwho-1737537

ABSTRACT

Oxidative stress is the state of imbalance between the production of reactive oxygen species (free radicals) in the biological system and the ability of the body to detoxify them resulting in increased accumulation of free radicals in the cells. This stress leads to weakening of the immune system thus leading to higher susceptibility to other infections as well. This also includes the weakening of the respiratory tract leading to increased susceptibility of viral infections as in the case of COVID-19. Treatment for any kind of abnormality requires the identification of the key target proteins and pathways that are being altered. Withania somnifera is being used in the traditional medicinal system to improve health and longevity thus creating a sense of mental as well as physical well being. The present study utilises network pharmacological approach to predict the potential oxidative stress targets of the three major withanolides: Withanolide A, withaferin A and withanone. Primarily, the targets of the individual withanolides were obtained from the Swiss target and DIGEP-pred databases and the GO terms and lead hits related to oxidative stress were retrieved from AMIGO2 database. Totally 40 correlative hits were obtained as anti stress targets of the withanolides, which were subjected to functional enrichment and protein-protein interaction analysis to study the enriched pathways underlying oxidative stress response. Further the eleven crucial targets of the four selected pathways were analysed using molecular docking analysis. A total of forty protein hits were obtained as oxidative stress targets of the withanolides. Further, the pathway enrichment of these forty target genes showed the AGE RAGE signalling pathway as highly enriched pathway. Therefore, the AGE RAGE signalling pathway along with its underlying pathways namely MAPK signalling pathway, FOXO pathway and PI3-AKT pathway were chosen among all the other enriched pathways. Further the molecular docking analysis of the eleven target proteins falling under these four pathways showed good docking scores of the withanolides with all the eleven targets with highest interaction against BCL2. From the above study, the biological targets and associated pathways of the withanolides have been retrieved. Thus the in silico approach undertaken in this study explores the role of the key withanolides in the antioxidant potential of the traditional medicinal plant Withania somnifera. © The authors.

6.
World Journal of Dentistry ; 12(6):504-509, 2021.
Article in English | Scopus | ID: covidwho-1551754

ABSTRACT

Aim and objective: Based on the published research, this article aims to systematically review the in vivo effectiveness of povidone-iodine (PVP-I) mouth gargles in reducing salivary viral load in COVID-19 patients. Materials and methods: The inhibitory potential of different variables such as PVP-I, chlorhexidine gluconate (CHX), cetylpyridinium chloride (CPC), saline, and hydrogen peroxide (H2O2) were tested against SARS-CoV-2 in recent clinical trials. In this systematic review, appropriate randomized controlled trials (RCTs) for the evidence-based question: “what is the efficacy of PVP-I mouth gargle in reducing salivary viral load in COVID-19 patients?” were searched in Medline/PubMed, Scopus, Science Direct, Embase, Google Scholar, and the Cochrane Library database from January 15, 2020, to June 15, 2021, based on defined inclusion and exclusion criteria. From the selected articles, their references and reviews relevant to our topic were also looked for any missed studies. Results: After a pertinent search for appropriate studies, five in vivo RCTs were selected and others were excluded. All the trials used reverse transcription-polymerase chain reaction (RT-PCR) for mRNA detection and quantitation. Povidone-iodine mouth gargle (0.5–1%) used by COVID-19 patients 4th hourly effectively reduced salivary SARS-CoV-2 viral load, thereby reducing the carriage of infectious virion in adults. Statistically significant increase in Ct values, post 5, 15, and 45 minutes, 3 and 6 hours post-rinsing demonstrated the strong antiviral effect of PVP-I. Conclusion: In this COVID-19 pandemic, based on the published evidence of a few in vivo RCTs, it can be concluded that 0.5 to 1% PVP-I mouth gargle has the potency to effectively reduce the salivary SARS-CoV-2 viral load. To reinforce the use of PVP-I mouth gargles against SARS-CoV-2, this systematic review emphasizes the necessity for future research that is highly focused, robust, and has consistent techniques and a large sample size. Clinical significance: Research on the efficacy of PVP-I mouth gargle should be framed to focus on the most effective minimal concentration, exposure time, and volume of mouth gargle as well as the SARS-CoV-2 strain. The effect of PVP-I mouth gargles on viral infectivity and their cytotoxic effect on epithelial cells were not distinguished in the studies reviewed. Hence, viral cell culture technique should be employed to establish the potential virucidal activity of PVP-I against SARS-CoV-2. Host immunity against SARS-CoV-2 should also be considered in assessing the effectiveness of mouth gargles. © The Author(s).

9.
British Journal of Surgery ; 108:14-14, 2021.
Article in English | Web of Science | ID: covidwho-1254446
SELECTION OF CITATIONS
SEARCH DETAIL